MedCap AB (publ) (ST:MCAP) — Market Cap & Net Worth
Market Cap & Net Worth: MedCap AB (publ) (MCAP)
MedCap AB (publ) (ST:MCAP) has a market capitalization of $908.36 Million (Skr8.44 Billion) as of August 5, 2026. Listed on the ST stock exchange, this Sweden-based company holds position #9206 globally and #144 in its home market, demonstrating a 0.99% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying MedCap AB (publ)'s stock price Skr562.00 by its total outstanding shares 15019141 (15.02 Million). See MedCap AB (publ) (MCAP) reinvestment ratio to understand how much of operating cash flow is reinvested back into capital assets.
MedCap AB (publ) Market Cap History: 2015 to 2026
MedCap AB (publ)'s market capitalization history from 2015 to 2026. Data shows growth from $50.91 Million to $908.36 Million (34.07% CAGR).
MedCap AB (publ) Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how MedCap AB (publ)'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.42x
MedCap AB (publ)'s market cap is 0.42 times its annual revenue
Latest Price to Earnings (P/E) Ratio
4.04x
MedCap AB (publ)'s market cap is 4.04 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $56.09 Million | $851.67 Million | $73.00K | 0.07x | 768.30x |
| 2017 | $72.73 Million | $411.20 Million | $2.10 Million | 0.18x | 34.63x |
| 2018 | $128.33 Million | $709.00 Million | $600.00K | 0.18x | 213.89x |
| 2019 | $224.67 Million | $757.10 Million | $53.70 Million | 0.30x | 4.18x |
| 2020 | $371.75 Million | $817.40 Million | $60.90 Million | 0.45x | 6.10x |
| 2021 | $287.70 Million | $916.30 Million | $96.50 Million | 0.31x | 2.98x |
| 2022 | $349.93 Million | $1.11 Billion | $117.60 Million | 0.31x | 2.98x |
| 2023 | $545.50 Million | $1.59 Billion | $172.20 Million | 0.34x | 3.17x |
| 2024 | $971.40 Million | $1.81 Billion | $207.40 Million | 0.54x | 4.68x |
| 2025 | $887.35 Million | $2.11 Billion | $219.80 Million | 0.42x | 4.04x |
Competitor Companies of MCAP by Market Capitalization
Companies near MedCap AB (publ) in the global market cap rankings as of August 5, 2026.
Key companies related to MedCap AB (publ) by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #113 globally with a market cap of $186.27 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #180 globally with a market cap of $130.57 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #233 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #239 globally with a market cap of $103.60 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #113 | Abbott Laboratories | NYSE:ABT | $186.27 Billion | $107.12 |
| #180 | Stryker Corporation | NYSE:SYK | $130.57 Billion | $341.20 |
| #233 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #239 | Medtronic PLC | NYSE:MDT | $103.60 Billion | $86.68 |
MedCap AB (publ) Historical Marketcap From 2015 to 2026
Between 2015 and today, MedCap AB (publ)'s market cap moved from $50.91 Million to $ 908.36 Million, with a yearly change of 34.07%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Skr908.36 Million | +2.37% |
| 2025 | Skr887.35 Million | -8.65% |
| 2024 | Skr971.40 Million | +78.07% |
| 2023 | Skr545.50 Million | +55.89% |
| 2022 | Skr349.93 Million | +21.63% |
| 2021 | Skr287.70 Million | -22.61% |
| 2020 | Skr371.75 Million | +65.47% |
| 2019 | Skr224.67 Million | +75.06% |
| 2018 | Skr128.33 Million | +76.44% |
| 2017 | Skr72.73 Million | +29.68% |
| 2016 | Skr56.09 Million | +10.16% |
| 2015 | Skr50.91 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 4th, 2026 the market cap of MedCap AB (publ) was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $908.36 Million USD |
| MoneyControl | $908.36 Million USD |
| MarketWatch | $908.36 Million USD |
| marketcap.company | $908.36 Million USD |
| Reuters | $908.36 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About MedCap AB (publ)
MedCap AB (publ) is a private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, and buyout. It prefers to invest in Biotechnology; Life sciences; Pharmaceuticals; MedTech including healthcare equipment, software, components, and packaging solutions for life science products; an… Read more